Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Mustang Bio (MBIO) Tops Q1 EPS by 2c
May 10, 2019 7:40 AM EDTMustang Bio (NASDAQ: MBIO) reported Q1 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36).
As of March 31, 2019, Mustangs consolidated cash, cash equivalents, short-term investments (certificates of deposit) and restricted cash totaled $41.1 million, compared to $34.6 million as of December 31, 2018, an increase of $6.5 million for the quarter.Research and development expenses were $7.0 million for the first quarter of 2019, compared to $4.3 million for the first quarter of 2018. Non-cash, stock-based compensation expenses included in research and development were $0.1 million for first quarter of 2019, compared to $1.5 million for the first quarter of 2018.Research and development... MoreFortress Biotech (FBIO) Tops Q1 EPS by 60c, Slight Beat on Revenues
May 10, 2019 7:39 AM EDTFortress Biotech (NASDAQ: FBIO) reported Q1 EPS of $0.02, $0.60 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $6.48 million versus the consensus estimate of $6.41 million.
As of March 31, 2019, Fortress consolidated cash, cash equivalents, short-term investments (certificates of deposit), and restricted cash totaled $137.5 million, compared to $99.2 million as of December 31, 2018, an increase of $38.3 million for the quarter.Fortress net revenue totaled $6.5 million for the first quarter of 2019, compared to $5.9 million for the first quarter of 2018.Research and development expenses were $23.3 million for the first quarter of 2019, of which $22.6 million... More